However, the strongest association with hypoglycemia-related ED visits and hospitalization was the choice of glucose level–lowering medication (for patients with type 2 diabetes), with use of prandial insulin and, to a lesser degree, basal insulin or sulfonylurea, conferring the highest risk. The gene discussed is INS; the disease is type 2 diabetes mellitus.